What is Organogenesis Holdings Inc.'s revenue?

Organogenesis Holdings Inc. (ORGO) generated $514.7M in revenue over the trailing twelve months, up 12.2% year over year.

Is Organogenesis Holdings Inc. profitable?

Organogenesis Holdings Inc. reported $2.7M in net income over the trailing twelve months, a 0.5% net margin.

What are Organogenesis Holdings Inc.'s profit margins?

Gross margin is 75.9% and operating margin is 0.5%, with a 0.5% net margin.

What is Organogenesis Holdings Inc.'s earnings per share?

Organogenesis Holdings Inc.'s diluted EPS over the trailing twelve months is $-0.16.

Where does Organogenesis Holdings Inc.'s income statement data come from?

Every line is extracted from Organogenesis Holdings Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Organogenesis Holdings Inc. ORGO Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Total revenue	$564.17M+17.0%	$482.04M+11.3%	$433.14M-3.9%	$450.89M-3.5%
Research and development	$44.54M-11.4%	$50.27M+13.3%	$44.38M+11.6%	$39.76M+29.3%
Selling, general and administrative	$326.24M+10.8%	$294.51M+9.2%	$269.75M-5.0%	$283.81M+13.4%
Other operating expenses	$519.48M+14.3%	$454.63M+8.1%	$420.62M+30.0%	$323.57M+15.2%
Total operating expenses	$519.48M+14.3%	$454.63M+8.1%	$420.62M+30.0%	$323.57M+15.2%
Total costs & expenses	$137.52M+18.8%	$115.74M+8.7%	$106.48M—	——
Operating income	$44.69M—	——	——	$22.3M-69.1%
Operating margin	7.9%—	——	——	4.9%-10.5pp
Interest expense	-$2.28M-242%	$1.61M-26.7%	$2.19M+7.4%	$2.04M-71.8%
Other income (expense), net	$2.28M+246%	-$1.56M+26.9%	-$2.13M-3.6%	-$2.06M+77.5%
Income before income taxes	$46.97M—	——	——	$20.28M-67.9%
Income tax expense	$9.94M—	——	——	$4.75M+115%
Net income	$37.03M+4,201%	$861K—	——	$15.53M-83.5%
Net margin	6.6%+6.4pp	0.2%—	——	3.4%-16.7pp
Diluted earnings per share	$0.11—	——	$0.04-66.7%	$0.12-82.6%
Basic earnings per share	$0.12—	——	$0.04-66.7%	$0.12-83.6%
Weighted-average shares, diluted	521.3M-1.6%	530M-0.1%	530.3M+0.8%	526M-1.7%
Weighted-average shares, basic	506.8M-4.1%	528.7M+0.7%	524.9M+1.1%	519.4M+1.3%
Write Down To Fair Value For Asset Held For Sale	$11.18M—	——	——	——
Cumulative Dividend On Redeemable Convertible Preferred Stock	$10.83M+681%	$1.39M—	$0—	$0—
Other income, net (Note 6)	-$5K—	——	——	——
Temporary Equity, Accretion to Redemption Value, Adjustment	$540K+31.1%	$412K—	$0—	$0—
EBIT	$44.69M—	——	——	$22.3M-69.1%
EBITDA	$59.97M—	——	——	$28.15M-66.1%
EBITDA	$59.97M—	——	——	$28.15M-66.1%
EBITDA margin	10.6%—	——	——	6.2%-11.5pp
EBIT	$44.69M—	——	——	$22.3M-69.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Organogenesis Holdings Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s revenue?: Organogenesis Holdings Inc. (ORGO) generated $514.7M in revenue over the trailing twelve months, up 12.2% year over year.
Is Organogenesis Holdings Inc. profitable?: Organogenesis Holdings Inc. reported $2.7M in net income over the trailing twelve months, a 0.5% net margin.
What are Organogenesis Holdings Inc.'s profit margins?: Gross margin is 75.9% and operating margin is 0.5%, with a 0.5% net margin.
What is Organogenesis Holdings Inc.'s earnings per share?: Organogenesis Holdings Inc.'s diluted EPS over the trailing twelve months is $-0.16.
Where does Organogenesis Holdings Inc.'s income statement data come from?: Every line is extracted from Organogenesis Holdings Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.